SiSaf’s Innovative RNA Therapeutic for Rare Genetic Skeletal Disorders Begins the U.S. Regulatory Process for Orphan Drug Designation

Published October 12, 2022

CSSi LifeSciences Partners with DevLab Bio to Speed Commercialization of Therapeutic and Medical Device Technologies

Published June 21, 2022

BioCurity Pharmaceuticals Inc. ('BioCurity' or ‘Company’) Announces Presentation at ACRO Summit 2022 on Sensitizing Head and Neck Cancer to Radiation Using the Company’s Cerium Oxide Nanoparticles | Business Wire

Published March 10, 2021